Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Chang YL, Fennema-Notestine C, Holland D, McEvoy LK, Stricker NH, Salmon DP, Dale AM, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 May;10(3):336-48. doi: 10.1016/j.jalz.2013.05.1763. Epub 2013 Jul 27.

PMID:
23896613
[PubMed - indexed for MEDLINE]
2.

Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J.

Am J Psychiatry. 2007 Jun;164(6):916-21.

PMID:
17541051
[PubMed - indexed for MEDLINE]
3.

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.

Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing; Harvard Aging Brain Study.

Neurology. 2014 May 20;82(20):1760-7. doi: 10.1212/WNL.0000000000000431. Epub 2014 Apr 18.

PMID:
24748674
[PubMed - indexed for MEDLINE]
4.

Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.

McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.

Neurosci Lett. 2010 Oct 8;483(1):62-6. doi: 10.1016/j.neulet.2010.07.063. Epub 2010 Aug 1.

PMID:
20678545
[PubMed - indexed for MEDLINE]
5.

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.

Dement Geriatr Cogn Disord. 2006;22(1):73-82. Epub 2006 May 12.

PMID:
16699282
[PubMed - indexed for MEDLINE]
Free Article
6.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
[PubMed - indexed for MEDLINE]
7.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
[PubMed - indexed for MEDLINE]
8.

Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.

Bizzarro A, Marra C, Acciarri A, Valenza A, Tiziano FD, Brahe C, Masullo C.

Dement Geriatr Cogn Disord. 2005;20(4):254-61. Epub 2005 Aug 9.

PMID:
16103669
[PubMed - indexed for MEDLINE]
9.

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.

Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.

Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.

PMID:
18334913
[PubMed - indexed for MEDLINE]
10.

Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.

Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 Sep;6(5):404-11. doi: 10.1016/j.jalz.2010.02.003.

PMID:
20813341
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.

PMID:
20479234
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.

Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C.

Dement Geriatr Cogn Disord. 2004;18(2):125-31. Epub 2004 Jun 18.

PMID:
15211066
[PubMed - indexed for MEDLINE]
13.

Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.

Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D; AIBL Research Group.

Brain. 2013 Jul;136(Pt 7):2201-16. doi: 10.1093/brain/awt127. Epub 2013 Jun 3.

PMID:
23737466
[PubMed - indexed for MEDLINE]
Free Article
14.

Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.

Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.

J Am Geriatr Soc. 2008 Apr;56(4):677-82. doi: 10.1111/j.1532-5415.2007.01606.x. Epub 2008 Jan 16.

PMID:
18205760
[PubMed - indexed for MEDLINE]
15.

Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.

Wahlund LO, Julin P, Lannfelt L, Lindqvist J, Svensson L.

Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):262-8.

PMID:
10364643
[PubMed - indexed for MEDLINE]
16.

Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.

Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.

Am J Psychiatry. 2006 Sep;163(9):1603-10.

PMID:
16946187
[PubMed - indexed for MEDLINE]
17.

Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.

Okonkwo OC, Xu G, Dowling NM, Bendlin BB, Larue A, Hermann BP, Koscik R, Jonaitis E, Rowley HA, Carlsson CM, Asthana S, Sager MA, Johnson SC.

Neurology. 2012 May 29;78(22):1769-76. doi: 10.1212/WNL.0b013e3182583047. Epub 2012 May 16.

PMID:
22592366
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
[PubMed - indexed for MEDLINE]
19.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
[PubMed - indexed for MEDLINE]
20.

The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease.

Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel S; EDSD study group.

Alzheimers Dement. 2014 May;10(3):401-4. doi: 10.1016/j.jalz.2013.02.008. Epub 2013 May 21.

PMID:
23706516
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk